首页> 外文期刊>Hormone and Metabolic Research >Functional and structural analysis of four novel mutations of CYP21A2 gene in Italian patients with 21-hydroxylase deficiency
【24h】

Functional and structural analysis of four novel mutations of CYP21A2 gene in Italian patients with 21-hydroxylase deficiency

机译:意大利21-羟化酶缺乏症患者CYP21A2基因四个新突变的功能和结构分析

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Congenital adrenal hyperplasia (CAH) is an autosomal recessive disorder mainly caused by defects in the 21-hydroxylase gene (CYP21A2), coding for the enzyme 21-hydroxylase (21-OH). About 95% of the mutations arise from gene conversion between CYP21A2 and the inactive pseudogene CYP21A1P: only 5% are novel CYP21A2 mutations, in which functional analysis of mutant enzymes has been helpful to correlate genotype-phenotype. In the present study, we describe 3 novel point mutations (p.L122P, p.Q481X, and p.E161X) in 3 Italian patients with CAH: the fourth mutation (p.M150R) was found in the carrier state. Molecular modeling suggests a major impact on 21-hydroxylase activity, and functional analysis after expression in COS-7 cells confirms reduced enzymatic activity of the mutant enzymes. Only the p.M150R mutation affected the activity to a minor extent, associated with NC CAH. CYP21A2 genotyping and functional characterization of each disease-causing mutation has relevance both for treatment and genetic counseling to the patients.
机译:先天性肾上腺增生(CAH)是一种常染色体隐性遗传疾病,主要由编码21-羟化酶(21-OH)的21-羟化酶基因(CYP21A2)的缺陷引起。大约95%的突变来自CYP21A2和非活性假基因CYP21A1P之间的基因转换:只有5%是新的CYP21A2突变,其中突变酶的功能分析已有助于关联基因型-表型。在本研究中,我们描述了3名意大利CAH患者的3个新的点突变(p.L122P,p.Q481X和p.E161X):第四个突变(p.M150R)处于携带状态。分子模型表明对21-羟化酶活性有重大影响,在COS-7细胞中表达后的功能分析证实了突变酶的酶活性降低。仅p.M150R突变在较小程度上影响了与NC CAH相关的活性。 CYP21A2的基因分型和每个致病突变的功能特征与治疗和对患者的遗传咨询均具有相关性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号